Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

Inclusion Criteria

• •1. Age ≥ 20 year old
• •2. In the case that the blood pressure at rest is greater than systolic 140mmHg or more than diastolic 90mmHg
• •3. When someone is taking Anti-Hypertensive medication
• •4. If total cholesterol is more than 200mg/dL and LDL-cholesterol is greater than 130mg/dL or if you are taking a statin
• •5. Significant coronary de novo lesion (\> 70% by quantitative angiographic analysis)
• •6. Patients with stable angina or acute coronary syndrome considered for percutaneous coronary intervention.
• •7. Reference vessel diameter of 2.5 to 3.5 mm by operator assessment
• •8. Stent size of 2.5 to 3.5 mm and stent length ≤ 24 mm